Observational Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Apr 26, 2022; 10(12): 3739-3753
Published online Apr 26, 2022. doi: 10.12998/wjcc.v10.i12.3739
Table 2 Data of secondary surgery for platinum-resistant recurrent epithelial ovarian carcinoma
Characteristic
Patients (n = 38)
Preoperative ECOG score, n (%)
0-133 (86.8)
25 (13.2)
Location of recurrent lesions, n (%)
Pelvic cavity7 (18.4)
Abdominopelvic cavity16 (42.1)
Pelvic/abdominal cavity + retroperitoneal15 (39.5)
Residual lesions of the secondary surgery, n (%)
R025 (65.8)
R1-R213 (34.2)
Intraoperative organ resection, n (%)
No13 (34.2)
Yes25 (65.8)
Bleeding amount (mL), n (%)
≤ 40020 (52.6)
401-80012 (31.6)
> 8016 (15.8)
Perioperative complications, n (%)
No29 (76.3)
Yes9 (23.7)
Postoperative chemotherapy, n (%)
No2 (5.3)
Yes36 (94.7)
Postoperative use of targeted drugs, n (%)
No33 (86.8)
Yes5 (13.2)
Postoperative hospital stay, n (%)
≤ 10 d24 (63.2)
11-20 d12 (31.6)
> 20 d2 (5.2)